A brief report of toxicity end points of HER2 vaccines for the treatment of patients with HER2+ breast cancer

A brief report of toxicity end points of HER2 vaccines for the treatment of patients with HER2+ breast cancer

Ricardo Costa,1 Saif Zaman,2 Susan Sharpe,3 Irene Helenowski,4 Colleen Shaw,1 Hyo Han,1 Hatem Soliman,1 Brian Czerniecki1 1Department of Breast Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA; 2Morsani College of Medicine, University of South Florida, Tampa, FL, USA; 3...

Full description

Bibliographic Details
Main Authors: Costa R, Zaman S, Sharpe S, Helenowski I, Shaw C, Han H, Soliman H, Czerniecki B
Format: Article
Language:English
Published: Dove Medical Press 2019-01-01
Series:Drug Design, Development and Therapy
Subjects:
HER2
vaccines
immunity
dendritic cells
toxicity
Online Access:https://www.dovepress.com/a-brief-report-of-toxicity-end-points-of-her2-vaccines-for-the-treatme-peer-reviewed-article-DDDT

Internet

https://www.dovepress.com/a-brief-report-of-toxicity-end-points-of-her2-vaccines-for-the-treatme-peer-reviewed-article-DDDT

Similar Items